Search Results
201 items found for "chronic kidney disease"
- GPR125 (ADGRA3) is an autocleavable adhesion GPCR that traffics with Dlg1 to the basolateral...
Here, we show that human GPR125 likely undergoes cis-autoproteolysis when expressed in canine kidney epithelial MDCK cells and human embryonic kidney HEK293 cells.
- Computational study of the conformational ensemble of CX3C chemokine receptor 1 (CX3CR1) and its...
macrophages and monocytes, and play a critical role in neuroinflammatory conditions such as Alzheimer's disease and multiple sclerosis, in the recovery from central nervous system injuries, in several chronic, peripheral
- 📰 GPCR Weekly News
Heptares and Lilly Enter Multi-target Collaboration and License Agreement in Diabetes and Metabolic Diseases Phase 2 Trial of INV-202, an Oral, Peripherally-acting CB1 Inverse Agonist, in Patients with Diabetic Kidney Disease Chris Cargill, President and CEO, will present a company overview at the 41st Annual J.P.
- Statin-induced increase in actin polymerization modulates GPCR dynamics and compartmentalization
In a recent work, we reported that chronic cholesterol depletion using statins leads to significant polymerization understanding the modulatory role of the membrane environment on the organization and dynamics of GPCRs in diseases
- C5aR2 receptor: The genomic twin of the flamboyant C5aR1
context-dependent compared to the C5aR1, which has received enormous attention for its role in both acute and chronic inflammatory diseases.
- 📰 GPCR Weekly News, July 1 to 7, 2024
for their investigation on Modulation of contextual fear acquisition and extinction by acute and chronic determines the potential of a GPCR for arrestin-biased agonism The roles of RGS proteins in cardiometabolic disease Receptor Responses to Sequential Injections of Pure and Mixed Sweeteners GPCRs involved in metabolic diseases signaling in murine brain tissue Modulation of contextual fear acquisition and extinction by acute and chronic
- Involvement of various chemokine/chemokine receptor axes in trafficking and oriented locomotion ...
mesenchymal stem cells in multiple sclerosis patients Multiple sclerosis (MS) is a specific type of chronic immune-mediated disease in which the immune responses are almost run against the central nervous system Despite intensive research, a known treatment for MS disease yet to be introduced. Thus, the development of novel and safe medications needs to be considered for the disease management
- Cholesterol-Dependent Dynamics of the Serotonin1A Receptor Utilizing Single Particle Tracking: ...
utilized single particle tracking (SPT) to monitor diffusion of serotonin1A receptors under acute and chronic in the confined population of the receptor accompanied by a reduction in diffusion coefficient for chronic supported by our recent work and present observations that show polymerization of G-actin in response to chronic
- Cholesterol-Dependent Dynamics of the Serotonin 1A Receptor Utilizing Single Particle Tracking....
utilized single particle tracking (SPT) to monitor diffusion of serotonin1A receptors under acute and chronic in the confined population of the receptor accompanied by a reduction in diffusion coefficient for chronic supported by our recent work and present observations that show polymerization of G-actin in response to chronic
- 📰 GPCR Weekly News, October 9 to 15, 2023
Nobel Laureates Highlight Symposium Celebrating Lefkowitz’s 50 Years at Duke Novo Nordisk stops Ozempic kidney trial after early signs of success Sosei and PharmEnable extend neurological disease drugs hunt Sosei
- 📰 GPCR Weekly News, August 7 to 13, 2023
technology with potential applications in chemical biology: a mini-review YAP/TAZ: Molecular pathway and disease therapy Primary cilia in skeletal development and disease Industry News Addex Reports 2023 Half Year Pharma to develop new therapies for people living with obesity, diabetes and other serious metabolic diseases Reports Second-Quarter 2023 Financial Results, Provides Corporate Updates, and Reports Emerging Data from Chronic
- Prostaglandin signaling in ciliogenesis and development
development, PGE2 signaling regulates embryogenesis, hepatocyte differentiation, hematopoiesis, and kidney
- 📰 GPCR Weekly News
GPCR Activation and Signaling Targeting GRK2 and GRK5 for treating chronic degenerative diseases: Advances
- The Bile Acid Membrane Receptor TGR5 in Cancer: Friend or Foe?
TGR5 is widely distributed in the brain, lung, heart, liver, spleen, pancreas, kidney, stomach, jejunum
- 📰 GPCR Weekly News, January 15 to 21, 2024
Targeting Giα1/3 APOL1-mediated monovalent cation transport contributes to APOL1-mediated podocytopathy in kidney disease Hepatocyte GPCR signaling regulates IRF3 to control hepatic stellate cell transdifferentiation transport by CCHCR1 via direct interaction Industry News Novartis Lutathera® significantly reduced risk of disease
- Regulators of G-protein signaling: essential players in GPCR signaling
Implications of RGS protein dysregulation in disease: The Dysregulation of RGS proteins has been implicated in a range of diseases, including cardiovascular disease, pain, hypertension, and cancer. In cardiovascular disease, RGS proteins play a critical role in regulating blood pressure and vascular The dysregulation of these proteins has been implicated in a range of diseases, and understanding the Avrampou, K., et al., RGS4 Maintains Chronic Pain Symptoms in Rodent Models.
- 📰 GPCR Weekly News
FFAR4 improves the senescence of tubular epithelial cells by AMPK/SirT3 signaling in acute kidney injury Immunology Germinal Center-Related G Protein-Coupled Receptors in Antibody-Mediated Autoimmune Skin Diseases quantitative systems pharmacology model for simulating OFF-Time in augmentation trials for Parkinson's disease
- 📰 GPCR Weekly News, March 20 to 26, 2023
Endocrinology, and Taste Green mamba peptide targets type-2 vasopressin receptor against polycystic kidney disease GPCRs in Oncology and Immunology Purinergic GPCR-integrin interactions drive pancreatic cancer
- Exploring the Breakthroughs in GPCR Research
structural approach Mechanisms controlling haemolymph circulation under resting conditions in the chagas disease Drivers of BCR-ABL1-Independent Imatinib Resistance and Six Herbal Compounds as Potential Drugs for Chronic , and more Class B1 GPCRs: Insights into Multi-Receptor Pharmacology for the Treatment of Metabolic Disease
- Chemokine receptor-targeted drug discovery: progress and challenges
chemokine receptor system is implicated in a wide range of inflammatory, autoimmune and infectious diseases a single receptor as patients cannot be stratified into CKRs specific subpopulations for a specific disease rigorous for this class, as the majority of potential therapeutic applications are situated in the area of chronic inflammatory disease (Proudfoot, Power, and Schwarz 2010).
- Use of CRISPR/Cas9-edited HEK293 cells reveals that both conventional and novel protein kinase C...
In this study, we generated and characterized human embryonic kidney 293A (HEK293A) cell lines devoid
- Exciting GPCR Events for Next Year! + GPCR Weekly Rocket Launch ⦿ Oct 28 - Nov 3, 2024
outstanding study on Class B1 GPCRs: insights into multireceptor pharmacology for the treatment of metabolic disease challenges Class B1 GPCRs: insights into multireceptor pharmacology for the treatment of metabolic disease for clinical development Chemokine CXCL13-CXCR5 signaling in neuroinflammation and pathogenesis of chronic pain and neurological diseases Structural and Molecular Insights into GPCR Function Native mass spectrometry
- Viral G Protein-Coupled Receptors Encoded by β- and γ-Herpesviruses
Finally, we briefly discuss the therapeutic targeting of vGPCRs as future treatment of acute and chronic
- Search for safer pain relief advances with new engineered compounds
November 2021 "Chronic use of most opioids causes tolerance; the new compounds avoid this and other unwanted
- Addex and Indivior Extend GABAB Positive Allosteric Modulator Research Collaboration for...
exclusive rights to develop its own independent GABAB PAM program, have also been expanded to include chronic
- 📰 GPCR Weekly News, March 27 to April 4, 2023
First complete genome sequence of lumpy skin disease virus directly from a clinical sample in South India Therapeutic potential of opioid receptor heteromers in chronic pain and associated comorbidities. Therapeutics Enters into Collaboration Agreement with Daiichi Sankyo to Discover Novel Medicines for CNS Diseases
- 📰 GPCR Weekly News, July 10 to 16, 2023
Immunology Ovarian cancer G protein-coupled receptor 1 (OGR1) deficiency exacerbates crystal deposition and kidney
- Odorant receptors – a bit of smell for drug discovery
In the human kidney ORs elicit intracellular Ca2+flux in renal proximal tubule cells via adenylyl cyclase to the diversity of the OR family it will be critical to select potential targets to modulate in a disease